Inhibition of Cytochrome P-450 3A (CYP3A) in Human Intestinal and Liver Microsomes: Comparison of Ki Values and Impact of CYP3A5 Expression
- 1 February 1999
- journal article
- research article
- Published by Elsevier in Drug Metabolism and Disposition
- Vol. 27 (2) , 180-187
- https://doi.org/10.1016/s0090-9556(24)15274-9
Abstract
No abstract availableThis publication has 38 references indexed in Scilit:
- Human liver carbamazepine metabolism: Role of CYP3A4 and CYP2C8 in 10,11-epoxide formationPublished by Elsevier ,2002
- The Kinetics of Aflatoxin B1Oxidation by Human cDNA-Expressed and Human Liver Microsomal Cytochromes P450 1A2 and 3A4Toxicology and Applied Pharmacology, 1996
- Differential Induction of Prehepatic and Hepatic Metabolism of Verapamil by RifampinHepatology, 1996
- Detection of a CYP3A5 Allelic Variant: A Candidate for the Polymorphic Expression of the Protein?Biochemical and Biophysical Research Communications, 1996
- The effects of ketoconazole on the intestinal metabolism and bioavailability of cyclosporine*Clinical Pharmacology & Therapeutics, 1995
- Interaction between grapefruit juice and midazolam in humans*Clinical Pharmacology & Therapeutics, 1995
- Disposition of intravenous and oral cyclosporine after administration with grapefruit juice*Clinical Pharmacology & Therapeutics, 1995
- Expression of Cytochrome-P450-3A5 in Escherichia Coli: Effects of 5′ Modification, Purification, Spectral Characterization, Reconstitution Conditions, and Catalytic ActivitiesArchives of Biochemistry and Biophysics, 1995
- Expression of Modified Human Cytochrome P450 3A4 in Escherichia coli and Purification and Reconstitution of the EnzymeArchives of Biochemistry and Biophysics, 1993
- The pharmacokinetics of midazolam in manEuropean Journal of Clinical Pharmacology, 1981